Amy C. Smith

1.0k total citations
22 papers, 672 citations indexed

About

Amy C. Smith is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, Amy C. Smith has authored 22 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Organic Chemistry. Recurrent topics in Amy C. Smith's work include Protein Kinase Regulation and GTPase Signaling (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Amy C. Smith is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Amy C. Smith collaborates with scholars based in United States, United Kingdom and Netherlands. Amy C. Smith's co-authors include George L. Bakris, Robert D. Toto, Nicholas J. Bach, Robert D. Dillard, Susan E. Draheim, Lea M. Johnson, Lawrence W. Hartley, David W. Snyder, Christopher B. Chapleo and Michael R. Stillings and has published in prestigious journals such as Kidney International, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Amy C. Smith

22 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy C. Smith United States 13 194 130 115 86 80 22 672
Qing Yu China 17 228 1.2× 26 0.2× 34 0.3× 61 0.7× 92 1.1× 51 634
Xiaochuan Wang China 17 161 0.8× 45 0.3× 66 0.6× 33 0.4× 23 0.3× 65 735
Xinying Zhang China 15 179 0.9× 65 0.5× 72 0.6× 26 0.3× 37 0.5× 46 716
Marie M. Gleason United States 24 574 3.0× 40 0.3× 406 3.5× 44 0.5× 47 0.6× 54 1.6k
Ning Zou China 17 177 0.9× 147 1.1× 117 1.0× 18 0.2× 36 0.5× 32 778
Soo Kyung Kim South Korea 16 302 1.6× 41 0.3× 170 1.5× 465 5.4× 30 0.4× 51 1.2k
Allen Mj United Kingdom 3 218 1.1× 41 0.3× 84 0.7× 346 4.0× 65 0.8× 3 887
Yiran Huang China 18 316 1.6× 79 0.6× 17 0.1× 40 0.5× 74 0.9× 77 998
Kathleen H. Wilson United States 17 103 0.5× 33 0.3× 158 1.4× 42 0.5× 58 0.7× 55 857
Jack Botting United Kingdom 13 129 0.7× 53 0.4× 70 0.6× 37 0.4× 177 2.2× 37 574

Countries citing papers authored by Amy C. Smith

Since Specialization
Citations

This map shows the geographic impact of Amy C. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy C. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy C. Smith more than expected).

Fields of papers citing papers by Amy C. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy C. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy C. Smith. The network helps show where Amy C. Smith may publish in the future.

Co-authorship network of co-authors of Amy C. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Amy C. Smith. A scholar is included among the top collaborators of Amy C. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy C. Smith. Amy C. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kiire, Christine A., et al.. (2015). Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema. Clinical ophthalmology. 2305–2305. 11 indexed citations
2.
Smith, Amy C., et al.. (2013). Strengthening Role Clarity in Acute Care Nurse Case Managers. Professional Case Management. 18(4). 190–198. 8 indexed citations
3.
Smith, Amy C.. (2013). Effect of telemonitoring on re-admission in patients with congestive heart failure.. PubMed. 22(1). 39–44. 8 indexed citations
4.
Smith, Amy C.. (2011). Role Ambiguity and Role Conflict in Nurse Case Managers. Professional Case Management. 16(4). 182–196. 35 indexed citations
5.
Smith, Amy C.. (2005). Middle Range Theory for Nursing. Clinical Nurse Specialist. 19(1). 49–49. 53 indexed citations
6.
Smith, Amy C., et al.. (2003). Safety of AdGVPEDF.11D Administered by Subtenon Injection Following Laser Disruption of the Bruch's Membrane in Cynomolgus Monkey Eyes. 44(13). 453–453. 2 indexed citations
7.
Bakris, George L., et al.. (2002). Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study. Journal of Human Hypertension. 16(3). 185–191. 27 indexed citations
8.
Smith, Amy C.. (2001). THE TREATMENT OF HYPERTENSION IN PATIENTS WITH DIABETES. Nursing Clinics of North America. 36(2). 273–289. 4 indexed citations
9.
Smith, Amy C., Leon Fogelfeld, & George L. Bakris. (2000). New therapies in diabetes – thiazolidinediones. 5(4). 441–456. 7 indexed citations
10.
Snyder, David W., Nicholas J. Bach, Robert D. Dillard, et al.. (1999). Pharmacology of LY315920/S-5920, [[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1 H-indol-4-yl]oxy]acetate, a Potent and Selective Secretory Phospholipase A2Inhibitor: A New Class of Anti-Inflammatory Drugs, SPI. Journal of Pharmacology and Experimental Therapeutics. 288(3). 1117–1124. 70 indexed citations
11.
Swindle, M. Michael, Amy C. Smith, & Joanna Goodrich. (1998). Chronic Cannulation and Fistulization Procedures in Swine: A Review and Recommendations. Journal of Investigative Surgery. 11(1). 7–20. 23 indexed citations
12.
Smith, Amy C., Robert D. Toto, & George L. Bakris. (1998). Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy. Kidney International. 54(3). 889–896. 79 indexed citations
13.
Draheim, Susan E., Nicholas J. Bach, Robert D. Dillard, et al.. (1997). ChemInform Abstract: Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. Part 3. Indole‐3‐glyoxamides.. ChemInform. 28(16). 3 indexed citations
14.
Abbott, Kevin C., Amy C. Smith, & George L. Bakris. (1996). Effects of Dihydropyridine Calcium Antagonists on Albuminuria in Patients with Diabetes. The Journal of Clinical Pharmacology. 36(3). 274–279. 23 indexed citations
15.
Draheim, Susan E., Nicholas J. Bach, Robert D. Dillard, et al.. (1996). Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 3. Indole-3-glyoxamides. Journal of Medicinal Chemistry. 39(26). 5159–5175. 76 indexed citations
16.
Fyfe, Derek A., et al.. (1995). Normal hematology, serology, and serum protein electrophoresis values in fetal Yucatan miniature swine.. PubMed. 45(3). 285–9. 12 indexed citations
17.
Granat, Malcolm, J. F. Keating, Amy C. Smith, Mark Delargy, & B.J. Andrews. (1992). The use of functional electrical stimulation to assist gait in patients with incomplete spinal cord injury. Disability and Rehabilitation. 14(2). 93–97. 43 indexed citations
18.
Chapleo, Christopher B., et al.. (1988). Substituted 1,3,4-thiadiazoles with anticonvulsant activity. 4. Amidines. Journal of Medicinal Chemistry. 31(1). 7–11. 82 indexed citations
19.
Granat, Malcolm, et al.. (1988). Characterization of the electrically excited flexion withdrawal response used in restoration of locomotion in spinal cord injured paraplegics. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 1675–1676 vol.4. 6 indexed citations
20.
Samoiloff, M. R. & Amy C. Smith. (1971). Fecundity of Panagrellus silusiae Treated with Ethyl methanesulphonate and 5-bromouracil.. PubMed Central. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qing Yu Breakdown of academic impact, for papers by Xiaochuan Wang Breakdown of academic impact, for papers by Xinying Zhang Breakdown of academic impact, for papers by Marie M. Gleason Breakdown of academic impact, for papers by Ning Zou Breakdown of academic impact, for papers by Soo Kyung Kim Breakdown of academic impact, for papers by Allen Mj Breakdown of academic impact, for papers by Yiran Huang Breakdown of academic impact, for papers by Kathleen H. Wilson Breakdown of academic impact, for papers by Jack Botting
Rankless by CCL
2026